Jefferies Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-577,965
| Closed | -$57.4M | – | 3283 |
|
|
2019
Q3 | $57.4M | Buy |
577,965
+231,027
| +67% | +$22M | 0.44% | 25 |
|
|
2019
Q2 | $32.1M | Buy |
346,938
+112,711
| +48% | +$10.7M | 0.23% | 56 |
|
|
2019
Q1 | $22.1M | Sell |
234,227
-16,911
| -7% | -$1.48M | 0.18% | 74 |
|
|
2018
Q4 | $16.1M | Buy |
251,138
+248,242
| +8,572% | +$18.3M | 0.13% | 116 |
|
|
2018
Q3 | $259K | Sell |
2,896
-612,856
| -100% | -$54.2M | ﹤0.01% | 1953 |
|
|
2018
Q2 | $48.9M | Buy |
615,752
+608,530
| +8,426% | +$50.5M | 0.27% | 44 |
|
|
2018
Q1 | $644K | Buy |
7,222
+4,141
| +134% | +$398K | ﹤0.01% | 1383 |
|
|
2017
Q4 | $322K | Buy |
3,081
+776
| +34% | +$87.6K | ﹤0.01% | 1975 |
|
|
2017
Q3 | $336K | Sell |
2,305
-32,696
| -93% | -$4.45M | ﹤0.01% | 1825 |
|
|
2017
Q2 | $4.55M | Sell |
35,001
-7,108
| -17% | -$871K | 0.03% | 579 |
|
|
2017
Q1 | $5.24M | Buy |
42,109
+22,457
| +114% | +$2.69M | 0.04% | 482 |
|
|
2016
Q4 | $2.27M | Sell |
19,652
-10,648
| -35% | -$1.19M | 0.01% | 889 |
|
|
2016
Q3 | $3.17M | Sell |
30,300
-24,858
| -45% | -$2.69M | 0.02% | 727 |
|
|
2016
Q2 | $5.44M | Buy |
55,158
+39,915
| +262% | +$4.13M | 0.02% | 471 |
|
|
2016
Q1 | $1.53M | Sell |
15,243
-150,859
| -91% | -$15.5M | 0.01% | 968 |
|
|
2015
Q4 | $19.9M | Sell |
166,102
-101,241
| -38% | -$11.7M | 0.11% | 144 |
|
|
2015
Q3 | $28.9M | Buy |
267,343
+103,534
| +63% | +$12.8M | 0.17% | 105 |
|
|
2015
Q2 | $19M | Buy |
163,809
+96,003
| +142% | +$11M | 0.1% | 171 |
|
|
2015
Q1 | $7.82M | Buy |
67,806
+17,355
| +34% | +$2.07M | 0.04% | 294 |
|
|
2014
Q4 | $5.64M | Buy |
50,451
+49,843
| +8,198% | +$5.26M | 0.03% | 393 |
|
|
2014
Q3 | $58K | Sell |
608
-12,121
| -95% | -$1.09M | ﹤0.01% | 1980 |
|
|
2014
Q2 | $1.09M | Sell |
12,729
-1,181
| -8% | -$89.8K | 0.01% | 878 |
|
|
2014
Q1 | $971K | Buy |
13,910
+8,592
| +162% | +$680K | 0.01% | 933 |
|
|
2013
Q4 | $449K | Buy |
5,318
+1,828
| +52% | +$145K | ﹤0.01% | 1203 |
|
|
2013
Q3 | $269K | Sell |
3,490
-26,660
| -88% | -$1.87M | ﹤0.01% | 1479 |
|
|
2013
Q2 | $1.76M | Buy |
+30,150
| New | +$1.81M | 0.02% | 561 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Jefferies Group's CELG Position: Q4 2019 in Review
Jefferies Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 577,965 shares — an estimated $57.4M sold.
Jefferies Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $57.4M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Jefferies Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Jefferies Group sold 577,965 Celgene Corp shares in Q4 2019, an estimated $57.4M.
- Jefferies Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Jefferies Group's Celgene Corp position peaked at $57.4M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.